Eloxx Pharmaceuticals, Inc. - FORM 10-K - EX-10.18 - EXHIBIT 10.18 - September 29, 2014

Attached files

file filename
EX-10.7 - EXHIBIT 10.7 - Eloxx Pharmaceuticals, Inc.v388379_ex10-7.htm
EXCEL - IDEA: XBRL DOCUMENT - Eloxx Pharmaceuticals, Inc.Financial_Report.xls
EX-23.1 - EXHIBIT 23.1 - Eloxx Pharmaceuticals, Inc.v388379_ex23-1.htm
EX-21.1 - EXHIBIT 21.1 - Eloxx Pharmaceuticals, Inc.v388379_ex21-1.htm
EX-10.14 - EXHIBIT 10.14 - Eloxx Pharmaceuticals, Inc.v388379_ex10-14.htm
EX-31.1 - EXHIBIT 31.1 - Eloxx Pharmaceuticals, Inc.v388379_ex31-1.htm
EX-32.2 - EXHIBIT 32.2 - Eloxx Pharmaceuticals, Inc.v388379_ex32-2.htm
EX-10.12 - EXHIBIT 10.12 - Eloxx Pharmaceuticals, Inc.v388379_ex10-12.htm
EX-31.2 - EXHIBIT 31.2 - Eloxx Pharmaceuticals, Inc.v388379_ex31-2.htm
EX-32.1 - EXHIBIT 32.1 - Eloxx Pharmaceuticals, Inc.v388379_ex32-1.htm
10-K - 10-K - Eloxx Pharmaceuticals, Inc.v388379_10k.htm
EX-10.9 - EXHIBIT 10.9 - Eloxx Pharmaceuticals, Inc.v388379_ex10-9.htm
EX-10.13 - EXHIBIT 10.13 - Eloxx Pharmaceuticals, Inc.v388379_ex10-13.htm
EX-10.28 - EXHIBIT 10.28 - Eloxx Pharmaceuticals, Inc.v388379_ex10-28.htm
EX-10.6 - EXHIBIT 10.6 - Eloxx Pharmaceuticals, Inc.v388379_ex10-6.htm
EX-10.44 - EXHIBIT 10.44 - Eloxx Pharmaceuticals, Inc.v388379_ex10-44.htm
EX-10.10 - EXHIBIT 10.10 - Eloxx Pharmaceuticals, Inc.v388379_ex10-10.htm
EX-10.26 - EXHIBIT 10.26 - Eloxx Pharmaceuticals, Inc.v388379_ex10-26.htm
EX-10.11 - EXHIBIT 10.11 - Eloxx Pharmaceuticals, Inc.v388379_ex10-11.htm
EX-10.8 - EXHIBIT 10.8 - Eloxx Pharmaceuticals, Inc.v388379_ex10-8.htm

 

Exhibit 10.18 

 

June 15, 2014

 

Dr. John Thompson

1438120 Ontario Limited

University of Waterloo

Waterloo, Ontario N2L 3G1

Canada

 

Re:      Amendment #9 to Consulting Agreement of July 12, 1999

 

Dear Dr. Thompson:

 

This will modify paragraph 11 of your Consulting Agreement with Senesco dated July 12, 1999, as modified.

 

Effective immediately, the term of the Consulting Agreement, as modified, will be extended for an additional 1 year term through June 30, 2015.

 

All other terms of the Agreement remain unchanged.

 

Sincerely,

  

Leslie J. Browne, Ph.D.

President

Senesco, Inc.

  

Acknowledged and Agreed:

 

/s/ John Thompson  
1438120 Ontario Limited  
Dr. John Thompson  

  

 

Eloxx Pharmaceuticals, Inc. Reports